Placulumab
Placulumab
Placulumab (pronounced pla-KU-lu-mab) is a type of monoclonal antibody used in the treatment of various diseases.
Etymology
The term "Placulumab" is derived from Latin roots. "Placu" is derived from "placere", meaning to please or appease, and "mab" is an abbreviation for "monoclonal antibody".
Usage
Placulumab is used in the treatment of diseases where the immune system is overactive or where there is a need to suppress the immune response. This includes conditions such as rheumatoid arthritis, multiple sclerosis, and certain types of cancer.
Mechanism of Action
As a monoclonal antibody, Placulumab works by binding to specific proteins on the surface of cells. This can block the action of these proteins, preventing them from causing damage to the body's tissues.
Related Terms
- Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Immune system: The body's defense against infectious organisms and other invaders.
- Rheumatoid arthritis: A chronic inflammatory disorder affecting many joints, including those in the hands and feet.
- Multiple sclerosis: A potentially disabling disease of the brain and spinal cord (central nervous system).
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
External links
- Medical encyclopedia article on Placulumab
- Wikipedia's article - Placulumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski